Carmignac Gestion’s Pfizer PFE Stock Holding History

Carmignac Gestion’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-46,120	Closed	-$1.88M	–	180
2023 Q1	$1.88M	Sell	46,120 -24,336	-35%	-$1.05M	0.03%	95
2022 Q4	$3.61M	Buy	70,456 +37,312	+113%	+$1.79M	0.07%	78
2022 Q3	$1.45M	Sell	33,144 -1,166,286	-97%	-$56.7M	0.03%	84
2022 Q2	$62.9M	Sell	1,199,430 -1,447,517	-55%	-$73.8M	1.33%	24
2022 Q1	$137M	Buy	2,646,947 +711,627	+37%	+$36.9M	2.21%	18
2021 Q4	$114M	Buy	+1,935,320	New	+$95.9M	1.6%	19
2019 Q4	–	Sell	-3,399,591	Closed	-$116M	–	134
2019 Q3	$116M	Buy	+3,399,591	New	+$124M	1.46%	26

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Carmignac Gestion's PFE Position: Q2 2023 in Review

Carmignac Gestion sold out of Pfizer (PFE) in Q2 2023, closing a stake of 46,120 shares — an estimated $1.88M sold.

Carmignac Gestion first reported a position in PFE in Q3 2019 and held it in 7 quarters. The position peaked at $137M in Q1 2022. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Carmignac Gestion reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Carmignac Gestion sold 46,120 Pfizer shares in Q2 2023, an estimated $1.88M.
Carmignac Gestion first reported a position in Pfizer in Q3 2019 and held it in 7 quarters.
Carmignac Gestion's Pfizer position peaked at $137M in Q1 2022.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Carmignac Gestion's 13F filing for Q2 2023, filed 11 Aug 2023.